S-1, Cisplatin-based Chemoradiotherapy, Induction Chemotherapy, Locally Advanced Gastric Adenocarcinoma
NCT02495493
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Gastric Adenocarcinoma
Interventions
DRUG:
Induction DCS chemotherapy
Sponsor
Yonsei University